Loading…

High Content Evaluation of Shear Dependent Platelet Function in a Microfluidic Flow Assay

The high blood volume requirements and low throughput of conventional flow assays for measuring platelet function are unsuitable for drug screening and clinical applications. In this study, we describe a microfluidic flow assay that uses 50  μ L of whole blood to measure platelet function on ~300 mi...

Full description

Saved in:
Bibliographic Details
Published in:Annals of biomedical engineering 2013-02, Vol.41 (2), p.250-262
Main Authors: Hansen, Ryan R., Wufsus, Adam R., Barton, Steven T., Onasoga, Abimbola A., Johnson-Paben, Rebecca M., Neeves, Keith B.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The high blood volume requirements and low throughput of conventional flow assays for measuring platelet function are unsuitable for drug screening and clinical applications. In this study, we describe a microfluidic flow assay that uses 50  μ L of whole blood to measure platelet function on ~300 micropatterned spots of collagen over a range of physiologic shear rates (50–920 s −1 ). Patterning of collagen thin films (CTF) was achieved using a novel hydrated microcontact stamping method. CTF spots of 20, 50, and 100  μ m were defined on glass substrates and consisted of a dense mat of nanoscale collagen fibers (3.74 ± 0.75 nm). We found that a spot size of greater than 20  μ m was necessary to support platelet adhesion under flow, suggesting a threshold injury size is necessary for stable platelet adhesion. Integrating 50  μ m CTF microspots into a multishear microfluidic device yielded a high content assay from which we extracted platelet accumulation metrics (lag time, growth rate, total accumulation) on the spots using Hoffman modulation contrast microscopy. This method has potential broad application in identifying platelet function defects and screening, monitoring, and dosing antiplatelet agents.
ISSN:0090-6964
1573-9686
1521-6047
DOI:10.1007/s10439-012-0658-5